Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutogliptin plus filgrastim after STEMI
NL-OMON48797Phase 2Active, not recruiting
- Sponsor
- Recardio Inc.
- Start
- Feb 2020
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dutogliptin and filgrastim, sponsored by Recardio Inc. Started Feb 2020; status: active, not recruiting.
02
Drugs
dutogliptinfilgrastim
Beyond the preview
Go deeper on NL-OMON48797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48797.